On Friday 14th April 2023 UnitedHealth Group reported full year and fourth quarter 2022 results reflecting broad-based growth at Optum and UnitedHealthcare.
Revenues of $324.2 Billion Grew 13% Year-Over-Year, with Double-Digit Growth at both Optum and UnitedHealthcare
Cash Flows from Operations were $26.2 Billion or 1.3x Net Income
Full Year and Fourth Quarter Net Earnings were $21.18 and $5.03 Per Share
Full Year and Fourth Quarter Adjusted Net Earnings were $22.19 and $5.34 Per Share
UnitedHealth Group affirmed the 2023 growth and performance objectives established at its November 29th Investor Conference, including revenues of
357 billion to 
360 billion, net earnings of $23.15 to $23.65 per share, adjusted net earnings of $24.40 to $24.90 per share and cash flows from operations of 
27 billion to 
28 billion.
Revenues of $324.2 Billion Grew 13% Year-Over-Year, with Double-Digit Growth at both Optum and UnitedHealthcare
Cash Flows from Operations were $26.2 Billion or 1.3x Net Income
Full Year and Fourth Quarter Net Earnings were $21.18 and $5.03 Per Share
Full Year and Fourth Quarter Adjusted Net Earnings were $22.19 and $5.34 Per Share
UnitedHealth Group affirmed the 2023 growth and performance objectives established at its November 29th Investor Conference, including revenues of
357 billion to 360 billion, net earnings of $23.15 to $23.65 per share, adjusted net earnings of $24.40 to $24.90 per share and cash flows from operations of 27 billion to 28 billion.
免責聲明
這些資訊和出版物並不意味著也不構成TradingView提供或認可的金融、投資、交易或其他類型的意見或建議。請在使用條款閱讀更多資訊。
免責聲明
這些資訊和出版物並不意味著也不構成TradingView提供或認可的金融、投資、交易或其他類型的意見或建議。請在使用條款閱讀更多資訊。